Display options
Cite
Walker LR, Hussein HA, Akula SM. Subcellular fractionation method to study endosomal trafficking of Kaposi's sarcoma-associated herpesvirus. Cell Biosci. 2016;6:1doi: 10.1186/s13578-015-0066-2.
Walker, L. R., Hussein, H. A., & Akula, S. M. (2016). Subcellular fractionation method to study endosomal trafficking of Kaposi's sarcoma-associated herpesvirus. Cell & bioscience, 61. https://doi.org/10.1186/s13578-015-0066-2
Walker, Lia R, et al. "Subcellular fractionation method to study endosomal trafficking of Kaposi's sarcoma-associated herpesvirus." Cell & bioscience vol. 6 (2016): 1. doi: https://doi.org/10.1186/s13578-015-0066-2
Walker LR, Hussein HA, Akula SM. Subcellular fractionation method to study endosomal trafficking of Kaposi's sarcoma-associated herpesvirus. Cell Biosci. 2016 Jan 15;6:1. doi: 10.1186/s13578-015-0066-2. eCollection 2016. PMID: 26779333; PMCID: PMC4714431.
Copy Download .nbib Format: NLM
Share it on

Cell Biosci. 2016 Jan 15;6:1. doi: 10.1186/s13578-015-0066-2. eCollection 2016.

Subcellular fractionation method to study endosomal trafficking of Kaposi's sarcoma-associated herpesvirus.

Cell & bioscience

Lia R Walker, Hosni A M Hussein, Shaw M Akula

Affiliations

  1. Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27834 USA.

PMID: 26779333 PMCID: PMC4714431 DOI: 10.1186/s13578-015-0066-2

Abstract

BACKGROUND: Virus entry involves multiple steps and is a highly orchestrated process on which successful infection collectively depends. Entry processes are commonly analyzed by monitoring internalized virus particles via Western blotting, polymerase chain reaction, and imaging techniques that allow scientist to track the intracellular location of the pathogen. Such studies have provided abundant direct evidence on how viruses interact with receptor molecules on the cell surface, induce cell signaling at the point of initial contact with the cell to facilitate internalization, and exploit existing endocytic mechanisms of the cell for their ultimate infectious agenda. However, there is dearth of knowledge in regards to trafficking of a virus via endosomes. Herein, we describe an optimized laboratory procedure to isolate individual organelles during different stages of endocytosis by performing subcellular fractionation. This methodology is established using Kaposi's sarcoma-associated herpesvirus (KSHV) infection of human foreskin fibroblast (HFF) cells as a model. With KSHV and other herpesviruses alike, envelope glycoproteins have been widely reported to physically engage target cell surface receptors, such as integrins, in interactions leading to entry and subsequent infection.

RESULTS: Subcellular fractionation was used to isolate early and late endosomes (EEs and LEs) by performing a series of centrifugations steps. Specifically, a centrifugation step post-homogenization was utilized to obtain the post-nuclear supernatant containing intact intracellular organelles in suspension. Successive fractionation via sucrose density gradient centrifugation was performed to isolate specific organelles including EEs and LEs. Intracellular KSHV trafficking was directly traced in the isolated endosomal fractions. Additionally, the subcellular fractionation approach demonstrates a key role for integrins in the endosomal trafficking of KSHV. The results obtained from fractionation studies corroborated those obtained by traditional imaging studies.

CONCLUSIONS: This study is the first of its kind to employ a sucrose flotation gradient assay to map intracellular KSHV trafficking in HFF cells. We are confident that such an approach will serve as a powerful tool to directly study intracellular trafficking of a virus, signaling events occurring on endosomal membranes, and dynamics of molecular events within endosomes that are crucial for uncoating and virus escape into the cytosol.

Keywords: Endocytosis; Endosomes; Fractionation; Sucrose density gradient; Ultracentrifugation; Virus entry

References

  1. J Virol. 2005 Jan;79(1):644-8 - PubMed
  2. Nat Med. 2012 Jun;18(6):961-6 - PubMed
  3. J Leukoc Biol. 2003 Feb;73(2):235-42 - PubMed
  4. Viruses. 2011 Jul;3(7):1015-40 - PubMed
  5. PLoS Biol. 2005 Jul;3(7):e233 - PubMed
  6. Mol Cell Biol. 2012 Dec;32(24):5022-34 - PubMed
  7. J Virol. 2001 Feb;75(3):1236-51 - PubMed
  8. Front Microbiol. 2012 Jan 20;3:6 - PubMed
  9. J Gen Virol. 2014 Aug;95(Pt 8):1770-82 - PubMed
  10. Blood. 2005 Jun 1;105(11):4516-22 - PubMed
  11. J Biol Chem. 2010 Nov 26;285(48):37491-502 - PubMed
  12. J Virol. 2010 Feb;84(4):2100-9 - PubMed
  13. PLoS One. 2012;7(2):e31652 - PubMed
  14. J Virol. 2012 Apr;86(7):4009-13 - PubMed
  15. J Virol. 2003 Mar;77(5):3131-47 - PubMed
  16. Proc Natl Acad Sci U S A. 2009 May 12;106(19):8003-8 - PubMed
  17. J Virol. 2008 Feb;82(3):1570-80 - PubMed
  18. PLoS Pathog. 2014 Feb 13;10(2):e1003941 - PubMed
  19. Pathogens. 2012 Dec;1(2):102-27 - PubMed
  20. J Neurosci Methods. 2013 Jul 15;217(1-2):67-74 - PubMed
  21. Biochim Biophys Acta. 2009 Apr;1793(4):605-14 - PubMed
  22. J Virol. 2004 Apr;78(7):3601-20 - PubMed
  23. Circ Res. 2003 May 16;92(9):962-8 - PubMed
  24. Cold Spring Harb Perspect Biol. 2013 Jan 01;5(1):a008755 - PubMed
  25. J Cell Sci. 2013 Mar 15;126(Pt 6):1289-95 - PubMed
  26. J Lipid Res. 2011 Mar;52(3):582-9 - PubMed
  27. Virology. 2010 May 25;401(1):18-28 - PubMed
  28. J Invest Dermatol. 2012 Jun;132(6):1733-5 - PubMed
  29. Arch Virol. 2015 Nov;160(11):2669-81 - PubMed
  30. J Virol. 2003 Jul;77(14):7978-90 - PubMed
  31. Cell Tissue Res. 2010 Jan;339(1):269-80 - PubMed
  32. J Biol Chem. 2002 May 17;277(20):17804-10 - PubMed
  33. Virology. 2001 Apr 10;282(2):245-55 - PubMed
  34. Science. 1999 Aug 13;285(5430):1028-32 - PubMed
  35. J Virol. 2008 Dec;82(24):12126-44 - PubMed
  36. J Virol. 2010 Mar;84(5):2188-99 - PubMed
  37. J Cell Biol. 2011 Dec 26;195(7):1071-82 - PubMed
  38. Virology. 2001 Jun 5;284(2):235-49 - PubMed
  39. Cell. 2002 Feb 8;108(3):407-19 - PubMed
  40. Mol Cell Biol. 2006 Oct;26(19):7269-82 - PubMed
  41. J Immunol. 2006 Feb 1;176(3):1741-9 - PubMed
  42. J Virol. 2010 Oct;84(19):10026-37 - PubMed

Publication Types